Search Results - "Numis, FG"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephrolithiasis by Mossetti, G., Vuotto, P., Rendina, D., Numis, F. G., Viceconti, R., Giordano, F., Cioffi, M., Scopacasa, F., Nunziata, V.

    Published in Journal of internal medicine (01-02-2003)
    “… Mossetti G, Vuotto P, Rendina D, Numis FG, Viceconti R, Giordano F, Cioffi M, Scopacasa F, Nunziata V (Federico II University Medical School, Naples, Italy)…”
    Get full text
    Journal Article
  2. 2

    Raloxifene administration in post‐menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypes by Palomba, Stefano, Numis, Fabio Giuliano, Mossetti, Giuseppe, Rendina, Domenico, Vuotto, Pietro, Russo, Tiziana, Zullo, Fulvio, Nappi, Carmine, Nunziata, Vincenzo

    Published in Human reproduction (Oxford) (01-01-2003)
    “…BACKGROUND: The vitamin D receptor (VDR) gene polymorphism has been considered a factor influencing the effectiveness of the anti‐osteoporotic treatments. The…”
    Get full text
    Journal Article
  3. 3

    Effectiveness of alendronate treatment in postmenopausal women with osteoporosis: relationship with BsmI vitamin D receptor genotypes by Palomba, Stefano, Numis, Fabio Giuliano, Mossetti, Giuseppe, Rendina, Domenico, Vuotto, Pietro, Russo, Tiziana, Zullo, Fulvio, Nappi, Carmine, Nunziata, Vincenzo

    Published in Clinical endocrinology (Oxford) (01-03-2003)
    “…Summary objective To assess whether there is a relationship between the effectiveness of alendronate treatment in postmenopausal women with osteoporosis and…”
    Get full text
    Journal Article
  4. 4

    Biochemical markers of bone turnover, serum levels of interleukin-6/interleukin-6 soluble receptor and bisphosphonate treatment in erdheim-chester disease by MOSSETTI, G, RENDINA, D, NUMIS, F. G, SOMMA, P, POSTIGLIONE, L, NUNZIATA, V

    Published in Clinical and experimental rheumatology (01-03-2003)
    “…Erdheim-Chester disease (ECD) is a rare non-Langherans form of histiocytosis characterized radiologically by symmetrical sclerosis of the metaphysis and the…”
    Get full text
    Journal Article
  5. 5

    Clodronate treatment reduces serum levels of interleukin-6 soluble receptor in Paget's disease of bone by RENDINA, D, POSTIGLIONE, L, VUOTTO, P, NUMIS, F. G, DI DOMENICO, G, VICECONTI, R, MOSSETTI, G, NUNZIATA, V

    Published in Clinical and experimental rheumatology (01-05-2002)
    “…Interleukin-6 (IL-6) and its soluble receptor (sIL-6R) stimulate osteoclast formation and activity. The primary cell abnormality in Paget's disease of bone…”
    Get full text
    Journal Article
  6. 6